RSS-Feed abonnieren

DOI: 10.1055/s-0045-1809900
Novel Nonsurgical Treatment Modality for Gastroduodenal Outlet Obstruction: A Randomized Controlled Trial
Authors
Funding None.

Abstract
Objectives
Gastric outlet obstruction (GOO) includes obstruction in the antropyloric area or in the bulbar or post-bulbar duodenum. Endoscopic balloon dilatation therapy combined with proton-pump inhibitors (PPIs) has been the standard of care. This study evaluates the efficacy of addition of misoprostol along with standard treatment versus standard treatment only in the treatment of GOO.
Materials and Methods
In this prospective, single-center, randomized controlled trial, consecutive patients of benign GOO were randomized into misoprostol + standard treatment (intervention arm) versus standard treatment only (control arm) into 1:1 ratio.
Statistical Analysis
Continuous variables were compared using t-tests, and categorical variables using chi-square tests. Note that p-values of < 0.05 were considered significant. Intention-to-treat analysis was performed.
Results
Forty patients of benign GOO were evaluated (mean age 36.05 ± 1.843, 57.5% males). Subjects in the intervention arm achieved significantly more procedural and clinical success (p 0.006 and 0.010), respectively. Improvement in nutritional status was significantly more in the intervention group (hemoglobin [p 0.015]; Δ albumin [p 0.032]), while the number of mean dilations required in them were significantly lower (p 0.004). The need for bypass surgery/reconstructive surgery was significantly lower in the control group (p 0.010). The side effect profile was similar in both the groups.
Conclusion
This study concludes that addition of misoprostol along with PPI and standard endoscopic therapy significantly improves the procedural success along with clinical outcome and nutritional status while obviating the need of surgical interventions of the patient with GOO.
Keywords
gastric outlet obstruction - misoprostol - endoscopic balloon dilatation - esophageal stricture - corrosiveAuthors' Contributions
Conceptualization: P.A.,M.S.,G.D., and S.N. Data curation: M.S.,G.D., and V.S.N. Formal analysis: All authors. Investigation: All authors. Methodology: P.A., G.S., G.D., and A.J. Project administration: P.A., A.J., and G.S. Resources: G.D., V.S.N., G.S., and S.N. Software: M.S., P.A., and G.S. Supervision: P.A., A.J., and S.N. Validation: P.A. and G.S. Visualization: P.A., M.S., and G.D. Writing-original draft: P.A., M.S., and V.S.N. Writing-review and editing: M.S., P.A., and G.S. All authors approved the final version of the article, including the authorship list.
Patients' Consent
Informed consent was taken from the patients.
Publikationsverlauf
Artikel online veröffentlicht:
01. Juli 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Khullar SK, DiSario JA. Gastric outlet obstruction. Gastrointest Endosc Clin N Am 1996; 6 (03) 585-603
- 2 Johnson CD, Ellis H. Gastric outlet obstruction now predicts malignancy. Br J Surg 1990; 77 (09) 1023-1024
- 3 Paimela H, Tuompo PK, Peräkyl T, Saario I, Höckerstedt K, Kivilaakso E. Peptic ulcer surgery during the H2-receptor antagonist era: a population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987. Br J Surg 1991; 78 (01) 28-31
- 4 Ferzoco SJ, Soybel DI. Gastric outlet obstruction, perforation, and other complications of gastroduodenal ulcer. In: Korman SH. ed. Therapy of Digestive Disorders. 1st ed.. Philadelphia, PA: Elsevier Inc; 2006: 357-372
- 5 Kreel L, Ellis H. Pyloric stenosis in adults: a clinical and radiological study of 100 consecutive patients. Gut 1965; 6 (03) 253-261
- 6 Hordijk ML, van Hooft JE, Hansen BE, Fockens P, Kuipers EJ. A randomized comparison of electrocautery incision with Savary bougienage for relief of anastomotic gastroesophageal strictures. Gastrointest Endosc 2009; 70 (05) 849-855
- 7 Kim JH, Song HY, Choi EK, Kim KR, Shin JH, Lim JO. Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur Radiol 2009; 19 (02) 384-390
- 8 Holm AN, de la Mora Levy JG, Gostout CJ, Topazian MD, Baron TH. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc 2008; 67 (01) 20-25
- 9 Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK. Ingestion of corrosive acids. Spectrum of injury to upper gastrointestinal tract and natural history. Gastroenterology 1989; 97 (03) 702-707
- 10 Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK. Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history. Am J Gastroenterol 1992; 87 (03) 337-341
- 11 Kalayarasan R, Ananthakrishnan N, Kate V. Corrosive Ingestion. Indian J Crit Care Med 2019; 23 (Suppl. 04) S282-S286
- 12 Allen-Brady K, Tuteja AK. Opioid-induced bowel disorder and narcotic bowel syndrome. In: Houghton LA. ed. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. 2nd ed.. San Diego, CA: Academic Press; 2023: 375-389
- 13 Joshi A, Falodia S, Vyas A, Kumar N. Alarming incidence of gastric outlet obstruction related to NSAIDs and synthetic opioid in North West India. J Assoc Physicians India 2024; 72 (01) 14-16
- 14 Khansari M, Sohrabi M, Zamani F. The usage of opioids and their adverse effects in gastrointestinal practice: a review. Middle East J Dig Dis 2013; 5 (01) 5-16
- 15 Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007; 5 (10) 1126-1139 , quiz 1121–1122
- 16 Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?. Physiol Rev 2008; 88 (04) 1547-1565
- 17 Garris RE, Kirkwood CF. Misoprostol: a prostaglandin E1 analogue. Clin Pharm 1989; 8 (09) 627-644
- 18 Silverstein FE, Graham DY, Senior JR. et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123 (04) 241-249
- 19 Graham DY, Agrawal NM, Campbell DR. et al; NSAID-Associated Gastric Ulcer Prevention Study Group. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002; 162 (02) 169-175
- 20 Raskin JB, White RH, Jackson JE. et al. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 1995; 123 (05) 344-350
- 21 Hawkey CJ, Karrasch JA, Szczepañski L. et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338 (11) 727-734
- 22 Lindor KD, Barkin JS, Amaro P. et al. Comparison of controlled radial expansion ball oon dilators to conventional balloon dilators in patients with benign esophageal strictures. Gastrointest Endosc 2000; 51 (04) AB111
- 23 Vandraas KF, Spigset O, Mahic M, Slørdal L. Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol 2010; 66 (08) 823-829
- 24 Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med 2016; 176 (09) 1286-1293
- 25 Kochhar R, Malik S, Gupta P. et al. Etiological spectrum and response to endoscopic balloon dilation in patients with benign gastric outlet obstruction. Gastrointest Endosc 2018; 88 (06) 899-908
- 26 Chiu YC, Hsu CC, Chiu KW. et al. Factors influencing clinical applications of endoscopic balloon dilation for benign esophageal strictures. Endoscopy 2004; 36 (07) 595-600
- 27 Rana SS, Bhasin DK, Chandail VS. et al. Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc 2011; 25 (05) 1579-1584
- 28 Reddy AN, Budhraja M. Sucralfate therapy for lye-induced esophagitis. Am J Gastroenterol 1988; 83 (01) 71-73
- 29 Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002; 97 (01) 72-78
- 30 Sharma B, Birk J. Endoscopic dilation of corrosive strictures: is it safe?. Dig Dis Sci 2022; 67 (07) 2706-2707
- 31 Maharshi S, Sharma D, Sharma SS, Sharma KK, Pokharna R, Nijhawan S. Aetiology and clinical spectrum of gastric outlet obstruction in North West India. Trop Doct 2023; 53 (04) 433-436
- 32 Sharma B, Sharma N, Kumar R. et al. Etiological profile of mechanical gastric outlet obstruction in the sub-Himalayan ranges of North India. Trop Gastroenterol 2023; 44 (01) 17-22
- 33 Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK. Group of Investigators for the National Survey on Extent and Pattern of Substance Use in India. Magnitude of Substance Use in India. New Delhi, India: Ministry of Social Justice and Empowerment, Government of India; 2019
- 34 Tringali A, Giannetti A, Adler DG. Endoscopic management of gastric outlet obstruction disease. Ann Gastroenterol 2019; 32 (04) 330-337
- 35 Lau JY, Chung SC, Sung JJ. et al. Through-the-scope balloon dilation for pyloric stenosis: long-term results. Gastrointest Endosc 1996; 43 (2 Pt 1): 98-101
- 36 Kochhar R, Malik S, Reddy YR. et al. Endoscopic balloon dilatation is an effective management strategy for caustic-induced gastric outlet obstruction: a 15-year single center experience. Endosc Int Open 2019; 7 (01) E53-E61
- 37 Kim JH, Shin JH, Song HY. Benign strictures of the esophagus and gastric outlet: interventional management. Korean J Radiol 2010; 11 (05) 497-506
- 38 McNeice A, Tham TC. Endoscopic balloon dilation for benign gastric outlet obstruction: does etiology matter?. Gastrointest Endosc 2018; 88 (06) 909-911
- 39 Kochhar R, Poornachandra KS, Dutta U, Agrawal A, Singh K. Early endoscopic balloon dilation in caustic-induced gastric injury. Gastrointest Endosc 2010; 71 (04) 737-744
- 40 Chiu YC, Liang CM, Tam W. et al. The effects of endoscopic-guided balloon dilations in esophageal and gastric strictures caused by corrosive injuries. BMC Gastroenterol 2013; 13: 99
- 41 Solt J, Bajor J, Szabó M, Horváth OP. Long-term results of balloon catheter dilation for benign gastric outlet stenosis. Endoscopy 2003; 35 (06) 490-495
- 42 Hamzaoui L, Bouassida M, Ben Mansour I. et al. Balloon dilatation in patients with gastric outlet obstruction related to peptic ulcer disease. Arab J Gastroenterol 2015; 16 (3-4): 121-124
- 43 Kim JH, Song HY, Park SW. et al. Early symptomatic strictures after gastric surgery: palliation with balloon dilation and stent placement. J Vasc Interv Radiol 2008; 19 (04) 565-570
- 44 Sataloff DM, Lieber CP, Seinige UL. Strictures following gastric stapling for morbid obesity. Results of endoscopic dilatation. Am Surg 1990; 56 (03) 167-174
- 45 Kim JH, Shin JH, Bae JI. et al. Gastric outlet obstruction caused by benign anastomotic stricture: treatment by fluoroscopically guided balloon dilation. J Vasc Interv Radiol 2005; 16 (05) 699-704
- 46 Ray D, Chattopadhyay G. Surgical management of gastric outlet obstruction due to corrosive injury. Indian J Surg 2015; 77 (Suppl. 02) 662-665
- 47 Tseng YL, Wu MH, Lin MY, Lai WW. Early surgical correction for isolated gastric stricture following acid corrosion injury. Dig Surg 2002; 19 (04) 276-280
- 48 Hwang TL, Chen MF. Surgical treatment of gastric outlet obstruction after corrosive injury–can early definitive operation be used instead of staged operation?. Int Surg 1996; 81 (02) 119-121
